Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

This study aimed to investigate the independent and potential non-linear association between serum 25(OH)D levels and MetS in adults undergoing routine health examinations.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Secondary analysis.

Secondary analysis

Analyses existing study data; this paper is not automatically another independent trial.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Participants were excluded if they met any of the following criteria:

Source: Methods.

Given that this research entailed secondary analysis of an existing health examination database, involved no additional interventions or potential risks to participants, and all data were de-identified before the analytical process, the ethics committee granted a waiver for the requirement of informed consent.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Serum 25-hydroxyvitamin D and metabolic syndrome: a large cross-section study with dose response analysis in a health screening population

Secondary analysis · Frontiers in Nutrition · 2026

Original publication title

Serum 25-hydroxyvitamin D and metabolic syndrome: a large cross-section study with dose response analysis in a health screening population

Jia He; Ying-Yun Peng; Xiao-Kang Zhou; Yi-Na Shao; Hua-Fang Du; Hai-Zhen Wang; Tai-Wei Ye; Ying-Gang Chen

Copyright © 2026 He, Peng, Zhou, Shao, Du, Wang, Ye and Chen.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

In this large health screening: based population of 29,214 adults, higher serum 25(OH)D concentrations were independently associated with lower odds of metabolic syndrome after comprehensive adjustment for potential confounders. Although the findings support a robust inverse association, causal inference cannot be established, and residual confounding may remain. Prospective cohort studies and well-designed randomized trials are warranted to clarify whether vitamin D plays a causal role in the development of metabolic syndrome or primarily reflects underlying metabolic health status.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

The association between serum 25-hydroxyvitamin D [25(OH)D] and metabolic syndrome (MetS) remains controversial, particularly in large-scale health-screening populations where early metabolic abnormalities can be detected. This study aimed to investigate the independent and potential non-linear association between serum 25(OH)D levels and MetS in adults undergoing routine health examinations.

Source: Background

Abstract: What methods does the paper describe?

This cross-sectional study included 29,214 adults who underwent routine health examinations at a tertiary hospital between January 2024 and November 2025. MetS was defined according to the 2023 Chinese expert consensus criteria. Multivariable logistic regression models with sequential adjustment were used to estimate odds ratios (OR) and 95% confidence intervals (CI) across quartiles of serum 25(OH)D. Restricted cubic spline (RCS) analysis was performed to explore potential non-linear dose: response relationships. Sensitivity analyses included exclusion of outliers, additional adjustment for hepatic and renal function indicators, and E-value estimation to assess robustness to unmeasured confounding.

Source: Methods

Abstract: Results

Among 29,214 participants, 6,002 (20.5%) were diagnosed with MetS. After multivariable adjustment, higher serum 25(OH)D levels were independently associated with lower odds of MetS. Compared with the lowest quartile (Q1, <14.9 ng/mL), participants in the highest quartile (Q4, >25.2 ng/mL) had a 36% lower likelihood of MetS (OR = 0.64, 95% CI: 0.57 to 0.71). RCS analysis demonstrated an inverse dose: response relationship, with the strongest risk reduction observed above approximately 20 ng/mL.

Source: Results

Abstract: Conclusion

In this large health screening: based population of 29,214 adults, higher serum 25(OH)D concentrations were independently associated with lower odds of metabolic syndrome after comprehensive adjustment for potential confounders. Although the findings support a robust inverse association, causal inference cannot be established, and residual confounding may remain. Prospective cohort studies and well-designed randomized trials are warranted to clarify whether vitamin D plays a causal role in the development of metabolic syndrome or primarily reflects underlying metabolic health status.

Source: Conclusion
Authors’ abstract

Background

The association between serum 25-hydroxyvitamin D [25(OH)D] and metabolic syndrome (MetS) remains controversial, particularly in large-scale health-screening populations where early metabolic abnormalities can be detected. This study aimed to investigate the independent and potential non-linear association between serum 25(OH)D levels and MetS in adults undergoing routine health examinations.

Methods

This cross-sectional study included 29,214 adults who underwent routine health examinations at a tertiary hospital between January 2024 and November 2025. MetS was defined according to the 2023 Chinese expert consensus criteria. Multivariable logistic regression models with sequential adjustment were used to estimate odds ratios (OR) and 95% confidence intervals (CI) across quartiles of serum 25(OH)D. Restricted cubic spline (RCS) analysis was performed to explore potential non-linear dose: response relationships. Sensitivity analyses included exclusion of outliers, additional adjustment for hepatic and renal function indicators, and E-value estimation to assess robustness to unmeasured confounding.

Results

Among 29,214 participants, 6,002 (20.5%) were diagnosed with MetS. After multivariable adjustment, higher serum 25(OH)D levels were independently associated with lower odds of MetS. Compared with the lowest quartile (Q1, <14.9 ng/mL), participants in the highest quartile (Q4, >25.2 ng/mL) had a 36% lower likelihood of MetS (OR = 0.64, 95% CI: 0.57 to 0.71). RCS analysis demonstrated an inverse dose: response relationship, with the strongest risk reduction observed above approximately 20 ng/mL.

Conclusion

In this large health screening: based population of 29,214 adults, higher serum 25(OH)D concentrations were independently associated with lower odds of metabolic syndrome after comprehensive adjustment for potential confounders. Although the findings support a robust inverse association, causal inference cannot be established, and residual confounding may remain. Prospective cohort studies and well-designed randomized trials are warranted to clarify whether vitamin D plays a causal role in the development of metabolic syndrome or primarily reflects underlying metabolic health status.

Publication and source details

Original title: Serum 25-hydroxyvitamin D and metabolic syndrome: a large cross-section study with dose response analysis in a health screening population

Jia He; Ying-Yun Peng; Xiao-Kang Zhou; Yi-Na Shao; Hua-Fang Du; Hai-Zhen Wang; Tai-Wei Ye; Ying-Gang Chen

Frontiers in Nutrition · 2026

* Correspondence: Ying-Gang Chen, y75945886@163.com
†

These authors have contributed equally to this work

Copyright © 2026 He, Peng, Zhou, Shao, Du, Wang, Ye and Chen.2026He, Peng, Zhou, Shao, Du, Wang, Ye and Chenhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. This work was supported by the Jinhua Major & Key Science and Technology Program (Social Development Category) under Grant 2026-3-025.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T10:40:31.386255+00:00

DOI: 10.3389/fnut.2026.1809892 · PMC13174186